Mark E. Byrne

4.3k total citations
72 papers, 3.4k citations indexed

About

Mark E. Byrne is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Mark E. Byrne has authored 72 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 22 papers in Molecular Biology and 22 papers in Pharmaceutical Science. Recurrent topics in Mark E. Byrne's work include Ocular Surface and Contact Lens (25 papers), Advanced Drug Delivery Systems (20 papers) and Analytical chemistry methods development (14 papers). Mark E. Byrne is often cited by papers focused on Ocular Surface and Contact Lens (25 papers), Advanced Drug Delivery Systems (20 papers) and Analytical chemistry methods development (14 papers). Mark E. Byrne collaborates with scholars based in United States, Ireland and Spain. Mark E. Byrne's co-authors include Nicholas A. Peppas, Kinam Park, Jonas Hilt, Charles J. White, Maryam Ali, Siddarth Venkatesh, Jacek Wower, Andreas Heise, Kayla M. Pate and Matthew K. McBride and has published in prestigious journals such as Biomaterials, Chemistry of Materials and Advanced Drug Delivery Reviews.

In The Last Decade

Mark E. Byrne

71 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Byrne United States 32 1.0k 930 863 743 710 72 3.4k
Nathalie Mignet France 34 171 0.2× 464 0.5× 1.2k 1.4× 1.3k 1.8× 34 0.0× 165 3.9k
Lasse Murtomäki Finland 29 154 0.2× 415 0.4× 695 0.8× 671 0.9× 41 0.1× 121 3.0k
Scott G. Harroun Canada 26 232 0.2× 119 0.1× 984 1.1× 664 0.9× 39 0.1× 51 2.7k
Adrian Hawley Australia 31 62 0.1× 513 0.6× 480 0.6× 1.2k 1.6× 62 0.1× 119 3.4k
Shubin Jin China 27 150 0.1× 306 0.3× 2.5k 2.9× 1.8k 2.4× 21 0.0× 47 5.3k
Barbara Stella Italy 31 116 0.1× 565 0.6× 1.1k 1.2× 1.6k 2.2× 23 0.0× 86 3.9k
Pankaj Dwivedi India 23 209 0.2× 348 0.4× 263 0.3× 375 0.5× 37 0.1× 73 1.5k
Na Li China 36 69 0.1× 279 0.3× 1.3k 1.5× 2.2k 3.0× 98 0.1× 148 3.9k
Yashveer Singh India 27 71 0.1× 257 0.3× 457 0.5× 1.0k 1.4× 29 0.0× 72 2.3k
Élodie Boisselier Canada 20 115 0.1× 148 0.2× 1.3k 1.5× 1.7k 2.3× 27 0.0× 60 5.1k

Countries citing papers authored by Mark E. Byrne

Since Specialization
Citations

This map shows the geographic impact of Mark E. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Byrne more than expected).

Fields of papers citing papers by Mark E. Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Byrne. The network helps show where Mark E. Byrne may publish in the future.

Co-authorship network of co-authors of Mark E. Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Byrne. A scholar is included among the top collaborators of Mark E. Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Byrne. Mark E. Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
George‐Weinstein, Mindy, et al.. (2024). Evaluation of Dose–Response Relationship in Novel Extended Release of Targeted Nucleic Acid Nanocarriers to Treat Secondary Cataracts. Journal of Ocular Pharmacology and Therapeutics. 40(7). 459–466.
2.
Byrne, Mark E., et al.. (2024). Methodology for high-performance liquid chromatography detection of latanoprost and latanoprost free acid. Acta Chromatographica. 37(1). 67–75. 2 indexed citations
3.
Boyle, Brian, et al.. (2024). Hollow Polyethyleneimine Nanoparticles with Drug Loaded DNA for Chemotherapeutic Applications. ChemPlusChem. 89(8). e202400129–e202400129. 1 indexed citations
4.
Behl, Gautam, et al.. (2023). NAD+-associated-hyaluronic acid and poly(L-lysine) polyelectrolyte complexes: An evaluation of their potential for ocular drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 192. 62–78. 3 indexed citations
5.
Maldonado, Daniel Bonilla, et al.. (2021). Review of Contemporary Self-Assembled Systems for the Controlled Delivery of Therapeutics in Medicine. Nanomaterials. 11(2). 278–278. 61 indexed citations
6.
Byrne, Mark E., et al.. (2021). In vivo drug delivery via contact lenses: The current state of the field from origins to present. Journal of Drug Delivery Science and Technology. 63. 102413–102413. 16 indexed citations
7.
Maldonado, Daniel Bonilla, et al.. (2020). Extended Release of Doxorubicin-Loaded 3DNA Nanocarriers from In-Situ Forming, Self-Assembled Hydrogels. Journal of Ocular Pharmacology and Therapeutics. 36(6). 447–457. 3 indexed citations
8.
White, Charles J., et al.. (2016). Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses. Optometry and Vision Science. 93(4). 377–386. 36 indexed citations
9.
Byrne, Mark E., et al.. (2015). Star‐Shaped Polypeptides: Synthesis and Opportunities for Delivery of Therapeutics. Macromolecular Rapid Communications. 36(21). 1862–1876. 65 indexed citations
10.
Byrne, Mark E., et al.. (2013). Molecular weight and architectural dependence of well-defined star-shaped poly(lysine) as a gene delivery vector. Biomaterials Science. 1(12). 1223–1223. 85 indexed citations
11.
White, Charles J., et al.. (2013). Adjusting biomaterial composition to achieve controlled multiple-day release of dexamethasone from an extended-wear silicone hydrogel contact lens. Journal of Biomaterials Science Polymer Edition. 25(1). 88–100. 27 indexed citations
12.
Byrne, Mark E., et al.. (2012). The role of living/controlled radical polymerization in the formation of improved imprinted polymers. Journal of Molecular Recognition. 25(6). 361–369. 23 indexed citations
13.
Wower, Jacek, et al.. (2012). A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic. Nanomedicine Nanotechnology Biology and Medicine. 8(7). 1143–1151. 26 indexed citations
14.
Byrne, Mark E., et al.. (2012). Therapeutic RNA aptamers in clinical trials. European Journal of Pharmaceutical Sciences. 48(1-2). 259–271. 213 indexed citations
15.
Pate, Kayla M., et al.. (2012). In vitro controlled release of an anti-inflammatory from daily disposable therapeutic contact lenses under physiological ocular tear flow. European Journal of Pharmaceutics and Biopharmaceutics. 81(1). 170–177. 80 indexed citations
16.
White, Charles J., et al.. (2011). Controlled drug release from contact lenses: a comprehensive review from 1965-present. Journal of Drug Delivery Science and Technology. 21(5). 369–384. 70 indexed citations
17.
Venkatesh, Siddarth, et al.. (2008). Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 69(3). 852–860. 75 indexed citations
18.
Ali, Maryam & Mark E. Byrne. (2008). Challenges and solutions in topical ocular drug-delivery systems. Expert Review of Clinical Pharmacology. 1(1). 145–161. 68 indexed citations
19.
Inada, Masaki, Mark E. Byrne, Michael Yu, et al.. (2006). Collagenases in skeletal development and remodeling. Matrix Biology. 25. S49–S50. 2 indexed citations
20.
Venkatesh, Siddarth, Mark E. Byrne, Nicholas A. Peppas, & J. Zach Hilt. (2005). Applications of biomimetic systems in drug delivery. Expert Opinion on Drug Delivery. 2(6). 1085–1096. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Mignet Breakdown of academic impact, for papers by Lasse Murtomäki Breakdown of academic impact, for papers by Scott G. Harroun Breakdown of academic impact, for papers by Adrian Hawley Breakdown of academic impact, for papers by Shubin Jin Breakdown of academic impact, for papers by Barbara Stella Breakdown of academic impact, for papers by Pankaj Dwivedi Breakdown of academic impact, for papers by Na Li Breakdown of academic impact, for papers by Yashveer Singh Breakdown of academic impact, for papers by Élodie Boisselier
Rankless by CCL
2026